Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.7.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
7 Months Ended 12 Months Ended
Dec. 31, 2015
Dec. 31, 2016
Income:    
Revenue $ 0 $ 0
Expenses:    
Research and development 4,798 300,985
General and administrative 118,655 383,784
Interest 11,800 60,082
Total expenses 135,253 744,851
Net loss $ (135,253) $ (744,851)
Loss per share:    
Basic and diluted (in dollars per share)   $ (0.002)
Weighted average shares outstanding, basic and diluted (in shares)   372,462,888